BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Pharm Country

  Protalex, Inc. Announces Acceptance Of Abstract Highlighting Findings From U.S. Phase 1(B) Trial Of PRTX-100 In Active Rheumatoid Arthritis Patients At The 2014 American College of Rheumatology Annual Meeting

  September 3, 2014

   · 

  1 min read
• Genetown

  Generex Biotechnology Corporation / Antigen Express, Inc. To Participate In BioPharm America™ 2014

  September 3, 2014

   · 

  4 min read
• Retroscreen Virology Limited Exhibiting At ERS 2014 Munich In September

  September 3, 2014

   · 

  2 min read
• Abcam plc Introduces Exclusive Range Of Highly Validated Antibody Conjugates

  September 3, 2014

   · 

  2 min read
• Business

  ICON Appoints Dr. Ira Spector As Executive Vice President, Analytics And Consulting

  September 3, 2014

   · 

  2 min read
• Genetown

  Ocular Therapeutix, Inc. To Present At Morgan Stanley 2014 Global Healthcare Conference

  September 3, 2014

   · 

  1 min read
• BioMidwest

  INSYS Therapeutics Named Arizona Bioscience Company Of The Year

  September 3, 2014

   · 

  1 min read
• Drug Development

  BioLineRx Ltd. Doses First Patient For BL-8040’s Second Indication As Novel Stem Cell Mobilization Treatment

  September 3, 2014

   · 

  7 min read
• Pharm Country

  mPhase Technologies, Inc. Presenting At NIBA Conference

  September 3, 2014

   · 

  1 min read
• Drug Development

  Alkermes plc Announces Completion Of Patient Enrollment In Phase 2 Study Of ALKS 3831, A Novel, Broad-Spectrum Oral Antipsychotic

  September 3, 2014

   · 

  6 min read